Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

PTCOG Gastrointestinal Subcommittee Lower Gastrointestinal Tract Malignancies Consensus Statement

J. Isabelle Choi, A. Wojcieszynski, RA. Amos, H. Giap, S. Apisarnthanarax, JB. Ashman, A. Anand, LA. Perles, T. Williamson, S. Ramkumar, J. Molitoris, CB. Simone, MD. Chuong

. 2024 ; 11 (-) : 100019. [pub] 20240426

Status neindexováno Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc24012915

PURPOSE: Radiotherapy delivery in the definitive management of lower gastrointestinal (LGI) tract malignancies is associated with substantial risk of acute and late gastrointestinal (GI), genitourinary, dermatologic, and hematologic toxicities. Advanced radiation therapy techniques such as proton beam therapy (PBT) offer optimal dosimetric sparing of critical organs at risk, achieving a more favorable therapeutic ratio compared with photon therapy. MATERIALS AND METHODS: The international Particle Therapy Cooperative Group GI Subcommittee conducted a systematic literature review, from which consensus recommendations were developed on the application of PBT for LGI malignancies. RESULTS: Eleven recommendations on clinical indications for which PBT should be considered are presented with supporting literature, and each recommendation was assessed for level of evidence and strength of recommendation. Detailed technical guidelines pertaining to simulation, treatment planning and delivery, and image guidance are also provided. CONCLUSION: PBT may be of significant value in select patients with LGI malignancies. Additional clinical data are needed to further elucidate the potential benefits of PBT for patients with anal cancer and rectal cancer.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24012915
003      
CZ-PrNML
005      
20240726151442.0
007      
ta
008      
240723e20240426xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ijpt.2024.100019 $2 doi
035    __
$a (PubMed)38757077
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Isabelle Choi, J $u Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA $u New York Proton Center, New York, New York, USA
245    10
$a PTCOG Gastrointestinal Subcommittee Lower Gastrointestinal Tract Malignancies Consensus Statement / $c J. Isabelle Choi, A. Wojcieszynski, RA. Amos, H. Giap, S. Apisarnthanarax, JB. Ashman, A. Anand, LA. Perles, T. Williamson, S. Ramkumar, J. Molitoris, CB. Simone, MD. Chuong
520    9_
$a PURPOSE: Radiotherapy delivery in the definitive management of lower gastrointestinal (LGI) tract malignancies is associated with substantial risk of acute and late gastrointestinal (GI), genitourinary, dermatologic, and hematologic toxicities. Advanced radiation therapy techniques such as proton beam therapy (PBT) offer optimal dosimetric sparing of critical organs at risk, achieving a more favorable therapeutic ratio compared with photon therapy. MATERIALS AND METHODS: The international Particle Therapy Cooperative Group GI Subcommittee conducted a systematic literature review, from which consensus recommendations were developed on the application of PBT for LGI malignancies. RESULTS: Eleven recommendations on clinical indications for which PBT should be considered are presented with supporting literature, and each recommendation was assessed for level of evidence and strength of recommendation. Detailed technical guidelines pertaining to simulation, treatment planning and delivery, and image guidance are also provided. CONCLUSION: PBT may be of significant value in select patients with LGI malignancies. Additional clinical data are needed to further elucidate the potential benefits of PBT for patients with anal cancer and rectal cancer.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Wojcieszynski, Andrzej $u Kaiser Permanente, Denver, Colorado, USA
700    1_
$a Amos, Richard A $u Department of Medical Physics & Biomedical Engineering, University College London, London, UK
700    1_
$a Giap, Huan $u Medical University of South Carolina, Charleston, South Carolina, USA
700    1_
$a Apisarnthanarax, Smith $u Department of Radiation Oncology, University of Washington, Seattle, Washington, USA
700    1_
$a Ashman, Jonathan B $u Department of Radiation Oncology, Mayo Clinic, Scottsdale, Arizona, USA
700    1_
$a Anand, Aman $u Department of Radiation Oncology, Mayo Clinic, Scottsdale, Arizona, USA
700    1_
$a Perles, Luis A $u Department of Radiation Physics, UT MD Anderson Cancer Center, Houston, Texas, USA
700    1_
$a Williamson, Tyler $u Department of Radiation Physics, UT MD Anderson Cancer Center, Houston, Texas, USA
700    1_
$a Ramkumar, Shanmugasundaram $u Proton Therapy UK, Prague, CZ
700    1_
$a Molitoris, Jason $u Department of Radiation Oncology, University of Maryland Medical Center, Baltimore, Maryland, USA
700    1_
$a Simone, Charles B $u Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA $u New York Proton Center, New York, New York, USA
700    1_
$a Chuong, Michael D $u Department of Radiation Oncology, Miami Cancer Institute, Miami, Florida, USA
773    0_
$w MED00215028 $t International journal of particle therapy $x 2331-5180 $g Roč. 11 (20240426), s. 100019
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38757077 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240723 $b ABA008
991    __
$a 20240726151435 $b ABA008
999    __
$a ok $b bmc $g 2125522 $s 1224778
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 11 $c - $d 100019 $e 20240426 $i 2331-5180 $m International journal of particle therapy $n Int J Part Ther $x MED00215028
LZP    __
$a Pubmed-20240723

Najít záznam

Citační ukazatele

Možnosti archivace